ANTONELLA BERETTA: Open Payments
NPI 1033898630 · NORTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 60 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,121 · 2025 $2,023
Food & beverage: $1,911Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $687 |
| Neurocrine BioSciences, Inc. | 15 | $462 |
| Indivior Inc. | 4 | $280 |
| Alkermes, Inc. | 8 | $233 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $121 |
| E.R. Squibb & Sons, L.L.C. | 5 | $114 |
| Axsome Therapeutics, Inc. | 5 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| ABBVIE INC. | 1 | $27 |
| Bausch Health US, LLC | 1 | $23 |
Products named: INGREZZA, AUSTEDO XR, UZEDY, SUBLOCADE, ARISTADA, CAPLYTA, COBENFY, VIVITROL.
Industry payments across FL — which companies pay providers there.
